Paul Pettit
Urogynecology and Reconstructive Pelvic Surgery Jacksonville, FL Medical Doctor
NPI 1689663304 CMS profile 121159
4500 San Pablo Rd S, Jacksonville, FL 32224
General payments
$26,879
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$290
Through program year 2024, Paul Pettit of Jacksonville, FL is reported in the CMS Open Payments database as having received $26,879 across 17 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $290 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 90th percentile of Urogynecology and Reconstructive Pelvic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $5,600 | 2 | |
| 2023 | General | $12,894 | 6 | |
| 2022 | General | $8,020 | 4 | |
| 2020 | General | $138 | 2 | |
| 2019 | General | $228 | 3 |
Beside peers
- Paul Pettit
- Urogynecology and Reconstructive Pelvic Surgery median
- Middle half of Urogynecology and Reconstructive Pelvic Surgery
- National median
In program year 2025, general payments to Paul Pettit were reported at $0. Among 802 Urogynecology and Reconstructive Pelvic Surgery profiles paid that year, the median was $412 and the middle half received between $133 and $1,300.
Show as a table
| Year | Paul Pettit | Urogynecology and Reconstructive Pelvic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $228 | $358 | $132–$1,270 | $163 |
| 2020 | $138 | $198 | $86–$642 | $114 |
| 2021 | $0 | $361 | $118–$1,182 | $132 |
| 2022 | $8,020 | $410 | $128–$1,175 | $149 |
| 2023 | $12,894 | $434 | $152–$1,344 | $160 |
| 2024 | $5,600 | $494 | $193–$1,331 | $164 |
| 2025 | $0 | $412 | $133–$1,300 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
17 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Urogynecology and Reconstructive Pelvic Surgery in Florida
Nathan Kow
Urogynecology and Reconstructive Pelvic Surgery · Orlando, FL
Amir Shariati
Urogynecology and Reconstructive Pelvic Surgery · Coconut Creek, FL
Charbel Salamon
Urogynecology and Reconstructive Pelvic Surgery · Orlando, FL
Allison Wyman
Urogynecology and Reconstructive Pelvic Surgery · Tampa, FL
Jose Lazaro Weiss
Urogynecology and Reconstructive Pelvic Surgery · Oviedo, FL
Arash Rahi
Urogynecology and Reconstructive Pelvic Surgery · Coconut Creek, FL
Related records
Urogynecology and Reconstructive Pelvic Surgery in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Urogynecology and Reconstructive Pelvic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.